Shugeng Gao

6.3k total citations · 1 hit paper
127 papers, 2.5k citations indexed

About

Shugeng Gao is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Shugeng Gao has authored 127 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Pulmonary and Respiratory Medicine, 53 papers in Oncology and 35 papers in Surgery. Recurrent topics in Shugeng Gao's work include Lung Cancer Diagnosis and Treatment (43 papers), Lung Cancer Treatments and Mutations (36 papers) and Cancer Immunotherapy and Biomarkers (23 papers). Shugeng Gao is often cited by papers focused on Lung Cancer Diagnosis and Treatment (43 papers), Lung Cancer Treatments and Mutations (36 papers) and Cancer Immunotherapy and Biomarkers (23 papers). Shugeng Gao collaborates with scholars based in China, United States and Japan. Shugeng Gao's co-authors include Qi Xue, Jie He, Yousheng Mao, Fengwei Tan, Wei Guo, Yushun Gao, Jianming Ying, Peng Song, Bolun Zhou and Juwei Mu and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Shugeng Gao

117 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer

2023 460 citations Heather A. Wakelee, Moïshe Liberman et al. profile →

Peers

Countries citing papers authored by Shugeng Gao

Since Specialization

Citations

This map shows the geographic impact of Shugeng Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shugeng Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shugeng Gao more than expected).

Fields of papers citing papers by Shugeng Gao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shugeng Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shugeng Gao. The network helps show where Shugeng Gao may publish in the future.

Co-authorship network of co-authors of Shugeng Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Shugeng Gao. A scholar is included among the top collaborators of Shugeng Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shugeng Gao. Shugeng Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In-situ observation and simulation of melt pool evolution and single-track formation in laser cladding 2025 ·Journal of Materials Research and Technology ·Shugeng Gao, Zijian Zhang, (unknown), Junfeng Li, Zhengying Wei	0
2	Health-related quality of life (HRQoL) outcomes from the randomized, double-blind phase 3 KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC). 2024 ·Journal of Clinical Oncology ·Marina Chiara Garassino, Heather A. Wakelee, Jonathan Spicer, Moïshe Liberman, Terufumi Kato, Masahiro Tsuboi, Se‐Hoon Lee, Ke‐Neng Chen, (unknown), Margarita Majem, E. Eigendorff, Gastón Lucas Martinengo, Olivier Bylicki, Delvys Rodríguez‐Abreu, Jamie E. Chaft, Jing Yang, Ashwini Arunachalam, Josephine M. Norquist, Steven M. Keller, Shugeng Gao	2
3	Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial 2024 ·Gastric Cancer ·(unknown), Yibin Xie, Wen Zhang, Chunxia Du, Yuxin Zhong, (unknown), Liming Jiang, Lizhou Dou, Kang Shao, Yongkun Sun, Qi Xue, Yantao Tian, Shugeng Gao, Dongbing Zhao, Aiping Zhou	10
4	Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma 2024 ·Nature Communications ·Zhenlin Yang, He Tian, (unknown), Bozhao Li, Guangyu Bai, (unknown), Jiachen Xu, Wei Guo, (unknown), Yue Peng, Qing Liang, Liyan Xue, Shugeng Gao	25
5	Association between radiotherapy and risk of second primary malignancies in patients with resectable lung cancer: a population-based study 2023 ·Journal of Translational Medicine ·Bolun Zhou, Ruochuan Zang, Peng Song, Moyan Zhang, Fenglong Bie, Guangyu Bai, Yuan Li, Qilin Huai, (unknown), Shugeng Gao	13
6	Utility of 18F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‑small cell lung cancer 2023 ·Translational Oncology ·Xiaowei Chen, Guangyu Bai, Ruochuan Zang, Peng Song, Fenglong Bie, Qilin Huai, Yuan Li, Yang Liu, Bolun Zhou, (unknown), Zhenlin Yang, Shugeng Gao	6
7	Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on B cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma 2022 ·Cancer Immunology Immunotherapy ·Peng Song, Wenbin Li, (unknown), Zhirong Qian, Jianming Ying, Shugeng Gao, Jie He	34
8	Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: A population-based study 2022 ·EBioMedicine ·Bolun Zhou, Ruochuan Zang, Moyan Zhang, Peng Song, (unknown), Fenglong Bie, Yue Peng, Guangyu Bai, Shugeng Gao	50
9	Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockade 2022 ·npj Precision Oncology ·Shuhang Wang, (unknown), Beibei Mao, Ning Li, Jianming Ying, Xiuli Tao, Wei Tang, Lei Zhang, (unknown), Fan Zhang, Qi Xue, Lijia Wu, Henghui Zhang, Shugeng Gao, Jie He	21
10	Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling 2022 ·EBioMedicine ·Wei Guo, Xin Chen, Rui Liu, Naixin Liang, Qianli Ma, Hua Bao, (unknown), Xue Wu, S Samuel Yang, Yang Shao, Fengwei Tan, Qi Xue, Shugeng Gao, Jie He	32
11	RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer 2022 ·EBioMedicine ·Bolun Zhou, Fenglong Bie, Ruochuan Zang, Moyan Zhang, Peng Song, Lei Liu, Yue Peng, Guangyu Bai, (unknown), Shugeng Gao	30
12	Integrating microarray-based spatial transcriptomics and single-cell RNA-sequencing reveals tissue architecture in esophageal squamous cell carcinoma 2022 ·EBioMedicine ·Wei Guo, Bolun Zhou, Zhenlin Yang, Xiang Liu, Qilin Huai, Lei Guo, Xuemin Xue, Fengwei Tan, Yin Li, Qi Xue, Shugeng Gao, Jie He	44
13	An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer 2021 ·Cancer Cell International ·Zhihui Zhang, Yuejun Luo, Chaoqi Zhang, Peng Wu, Guochao Zhang, (unknown), Lide Wang, Liyan Xue, Zhaoyang Yang, Hua Zeng, Bo Zheng, Fengwei Tan, Qi Xue, Shugeng Gao, Nan Sun, Jie He	6
14	Construction and validation of a novel immune and tumor mutation burden-based prognostic model in lung adenocarcinoma 2021 ·Cancer Immunology Immunotherapy ·Bolun Zhou, Shugeng Gao	8
15	Comprehensive analysis of PD-L1 expression, tumor-infiltrating lymphocytes, and tumor microenvironment in LUAD: differences between Asians and Caucasians 2021 ·Clinical Epigenetics ·Fenglong Bie, (unknown), Nan Sun, Ruochuan Zang, Moyan Zhang, Peng Song, (unknown), Yue Peng, Guangyu Bai, Bolun Zhou, Shugeng Gao	11
16	Uniportal video‐assisted thoracoscopic left pneumonectomy: Retrospective analysis of eighteen consecutive patients from a single center 2021 ·Thoracic Cancer ·Jiagen Li, Qi Xue, Yushun Gao, Yousheng Mao, Jun Zhao, Shugeng Gao	1
17	Associations between female lung cancer risk and sex steroid hormones: a systematic review and meta-analysis of the worldwide epidemiological evidence on endogenous and exogenous sex steroid hormones 2021 ·BMC Cancer ·Hui Zeng, (unknown), Jiang Li, Yan Wen, Zheng Wu, Yadi Zheng, Yiwen Yu, Yongjie Xu, Shugeng Gao, Fengwei Tan, Ni Li, Qi Xue, Jie He	9
18	Effectiveness of crizotinib in a patient with mesenchymal-epithelial transition overexpression/fluorescence in situ hybridization-negative/next-generation sequencing-negative advanced lung adenocarcinoma: a case report 2019 ·Translational Cancer Research ·Peng Song, Li Liu, Yutao Liu, Tao Zhang, Lei Guo, Weihua Li, Jianming Ying, Lin Yang, Shugeng Gao	1
19	Uniportal video‐assisted thoracic surgery could reduce postoperative thorax drainage for lung cancer patients 2019 ·Thoracic Cancer ·Jiagen Li, Bin Qiu, Marco Scarci, Gaetano Rocco, Shugeng Gao	13
20	[Comparison of lung cancer surgery in China, 2005 vs. 2015]. 2018 ·PubMed ·Ning Li, Fengwei Tan, Bin Qiu, Jiagen Li, Jun Zhao, Yushun Gao, Dali Wang, Yousheng Mao, Qi Xue, Juwei Mu, Shugeng Gao, Jie He	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact